Scholarlink

Background and purpose <p>Single-session, multiparametric [¹⁸F]FET PET/MRI is used to detect tumor recurrence in high-grade glioma, but its prognostic value for overall survival remains uncertain. This study evaluated whether biological tumor volume, tumor-to-background ratio (TBRmax), cerebral blood volume (rCBVmax), and choline/NAA ratio (Cho/NAA) could predict survival in recurrent high-grade glioma.</p> Materials and methods <p>Twenty-six patients with histopathologically confirmed tumor progression underwent simultaneous [¹⁸F]FET PET/MRI. PET-derived biological tumor volume and TBRmax, MRI-derived rCBVmax, and Cho/NAA ratio were analyzed. A Cox proportional hazards model assessed associations with overall survival, adjusting for the number of lesions and treatment strategy.</p> Results <p>Biological tumor volume (hazard ratio = 2.22, 95%-CI: 1.035–4.762, <i>p</i> = 0.041) and the number of lesions (hazard ratio = 1.03, 95%-CI 1.00–1.06, <i>p</i> = 0.036) were significantly associated with survival. TBRmax (<i>p</i> = 0.089), rCBVmax (<i>p</i> = 0.088), and Cho/NAA ratio (<i>p</i> = 0.734) were not predictive. Treatment strategy after tumor recurrence diagnosis did not significantly impact overall-survival (HR = 0.208, <i>p</i> = 0.649). PET/MRI interaction terms did not enhance survival prediction.</p> Conclusion <p>Biological tumor volume is a significant prognostic imaging biomarker in recurrent high-grade glioma, emphasizing tumor burden over metabolic activity or perfusion of individual lesions. Volume-based PET metrics may offer better survival prediction than traditional PET or MRI parameters. Prospective multicenter studies are needed to validate these findings and explore automated segmentation and machine learning approaches for improved prognostication.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biological tumor volume predicts survival in recurrent High-Grade glioma: A multiparametric [18F]FET PET/MRI study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月24日

查看全文
  • Dylan Henssen,
  • Michael Rullmann,
  • Anne I.J. Arens,
  • Andreas Schildan,
  • Stephan Striepe,
  • Matti Schürer,
  • Cordula Scherlach,
  • Katja Jähne,
  • Ruth Stassart,
  • Osama Sabri,
  • Clemens Seidel,
  • Swen Hesse

摘要

Background and purpose

Single-session, multiparametric [¹⁸F]FET PET/MRI is used to detect tumor recurrence in high-grade glioma, but its prognostic value for overall survival remains uncertain. This study evaluated whether biological tumor volume, tumor-to-background ratio (TBRmax), cerebral blood volume (rCBVmax), and choline/NAA ratio (Cho/NAA) could predict survival in recurrent high-grade glioma.

Materials and methods

Twenty-six patients with histopathologically confirmed tumor progression underwent simultaneous [¹⁸F]FET PET/MRI. PET-derived biological tumor volume and TBRmax, MRI-derived rCBVmax, and Cho/NAA ratio were analyzed. A Cox proportional hazards model assessed associations with overall survival, adjusting for the number of lesions and treatment strategy.

Results

Biological tumor volume (hazard ratio = 2.22, 95%-CI: 1.035–4.762, p = 0.041) and the number of lesions (hazard ratio = 1.03, 95%-CI 1.00–1.06, p = 0.036) were significantly associated with survival. TBRmax (p = 0.089), rCBVmax (p = 0.088), and Cho/NAA ratio (p = 0.734) were not predictive. Treatment strategy after tumor recurrence diagnosis did not significantly impact overall-survival (HR = 0.208, p = 0.649). PET/MRI interaction terms did not enhance survival prediction.

Conclusion

Biological tumor volume is a significant prognostic imaging biomarker in recurrent high-grade glioma, emphasizing tumor burden over metabolic activity or perfusion of individual lesions. Volume-based PET metrics may offer better survival prediction than traditional PET or MRI parameters. Prospective multicenter studies are needed to validate these findings and explore automated segmentation and machine learning approaches for improved prognostication.